3 results match your criteria: "Midwest Eye Institute and Indiana University Medical Center[Affiliation]"
Medicine (Baltimore)
March 2006
From Midwest Eye Institute and Indiana University Medical Center, Departments of Ophthalmology and Neurology (VP, A Kawasaki), Indianapolis, Indiana; Scott and White Eye Institute (KHS), Temple, Texas; and Tel Aviv Sourasky Medical Center, Department of Ophthalmology, Neuro-ophthalmology Unit (A Kesler), Tel Aviv, Israel.
A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described. We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug. In 1 case the drug appears to have exacerbated underlying myasthenic weakness, whereas in the other 3 cases, de novo antibody formation appears to be most likely.
View Article and Find Full Text PDFJ Neurol Neurosurg Psychiatry
January 2004
Midwest Eye Institute and Indiana University Medical Center, Department of Ophthalmology, Indianapolis, Indiana 46280, USA.
Aim: To characterise the clinical findings and natural history of anterior visual pathway compression by dolichoectatic intracranial vessels.
Methods: A retrospective case review of patients evaluated in an outpatient neuro-ophthalmology clinic.
Results: 10 patients with this condition were identified.
J Neuroophthalmol
June 2002
Midwest Eye Institute and Indiana University Medical Center, Department of Ophthalmology, Indianapolis 46280, USA.
A visually asymptomatic 27-year-old man was found to have inferior altitudinal visual field defects binocularly. Ophthalmoscopy revealed superior segmental optic pallor with superior nerve fiber layer atrophy, nicely highlighted in red-free photographs. The patient's mother had insulin-dependent diabetes mellitus.
View Article and Find Full Text PDF